Literature DB >> 15508204

Comparison of continuous and intermittent anorectic therapy in obesity.

J F Munro, A C MacCuish, E M Wilson, L J Duncan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 15508204      PMCID: PMC1984840          DOI: 10.1136/bmj.1.5588.352

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  6 in total

1.  CURRENT THERAPEUTICS. 203. SUSTAINED-ACTION CHLORPHENTERMINE IN THE CORRECTION OF REFRACTORY OBESITY.

Authors:  D A SEATON; K ROSE; L J DUNCAN
Journal:  Practitioner       Date:  1964-11

2.  THE LONG-TERM MANAGEMENT OF OBESITY IN GENERAL PRACTICE.

Authors:  J T SILVERSTONE; T SOLOMON
Journal:  Br J Clin Pract       Date:  1965-07

3.  Diethyl-propion in the treatment of "refractory" obesity.

Authors:  D A SEATON; L J DUNCAN; K ROSE; A M SCOTT
Journal:  Br Med J       Date:  1961-04-08

4.  Phenmetrazine hydrochloride and methylcellulose in the treatment of "refractory" obesity.

Authors:  L J DUNCAN; K ROSE; A P MEIKLEJOHN
Journal:  Lancet       Date:  1960-06-11       Impact factor: 79.321

5.  Treatment of refractory obesity with fenfluramine.

Authors:  J F Munro; D A Seaton; L J Duncan
Journal:  Br Med J       Date:  1966-09-10

6.  Obesity in childhood. A controlled trial of anorectic drugs.

Authors:  J Lorber
Journal:  Arch Dis Child       Date:  1966-06       Impact factor: 3.791

  6 in total
  34 in total

Review 1.  A risk-benefit assessment of anti-obesity drugs.

Authors:  J Kolanowski
Journal:  Drug Saf       Date:  1999-02       Impact factor: 5.606

2.  Extracts from "Clinical Evidence". Obesity.

Authors:  D Arterburn; P H Noël
Journal:  BMJ       Date:  2001-06-09

Review 3.  Antiobesity drugs: current and future issues.

Authors:  M Ammar Hatahet; Nikhil V Dhurandhar
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

Review 4.  New pharmacological approaches for obesity management.

Authors:  Christian F Rueda-Clausen; Raj S Padwal; Arya M Sharma
Journal:  Nat Rev Endocrinol       Date:  2013-06-11       Impact factor: 43.330

Review 5.  Obesity: Current and potential pharmacotherapeutics and targets.

Authors:  Vidya Narayanaswami; Linda P Dwoskin
Journal:  Pharmacol Ther       Date:  2016-10-20       Impact factor: 12.310

Review 6.  New tools for weight-loss therapy enable a more robust medical model for obesity treatment: rationale for a complications-centric approach.

Authors:  W Timothy Garvey
Journal:  Endocr Pract       Date:  2013 Sep-Oct       Impact factor: 3.443

Review 7.  The management of obesity.

Authors:  J M Court
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 8.  Anorectic drugs: use in general practice.

Authors:  D Craddock
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 9.  Long-term drug treatment for obesity: a systematic and clinical review.

Authors:  Susan Z Yanovski; Jack A Yanovski
Journal:  JAMA       Date:  2014-01-01       Impact factor: 56.272

Review 10.  Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.